Amyris logo

Amyris

ID: 2428352

Amyris is a synthetic biotechnology company that develops ingredients for consumer products in categories including health, beauty, flavors, and fragrances.

47

Funding Rounds

$1.5b

Money raised

Overview

Amyris is a synthetic biotechnology company that develops ingredients for consumer products in categories including health, beauty, flavors, and fragrances.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Amyris has raised a total of $2.33b in funding over 47 rounds.

Key Insights:

  • Amyris funding round, December 29, 2022: $50m
  • Amyris (company) Convertible note, November 15, 2021: $690m
  • Amyris funding round, April 2021: $130.7m
  • Amyris funding round, June 4, 2020: $200m
  • Amyris (company) Convertible note, November 15, 2019: $66m
  • Amyris funding round, November 12, 2019: $7.74m
  • Amyris funding round, September 9, 2019: $12.5m
  • Amyris funding round, April 29, 2019: $34m
  • Amyris funding round, December 7, 2018: $60m
  • Amyris funding round, August 21, 2018: $46m
  • Amyris Grant (money) funding round, January 18, 2018: $25m
  • Amyris funding round, August 3, 2017: $50m
  • Amyris funding round, May 30, 2017: $5.7m
  • Amyris funding round, May 8, 2017: $25m
  • Amyris funding round, September 30, 2016: $30m
  • Amyris funding round, June 28, 2016: $20m
  • Amyris funding round, June 24, 2016: $5m
  • Amyris funding round, May 10, 2016: $5m
  • Amyris funding round, April 11, 2016: $5m
  • Amyris funding round, February 19, 2016: $20m
  • Amyris funding round, October 18, 2015: $57.6m
  • Amyris funding round, July 29, 2015: $25m
  • Amyris funding round, August 14, 2014: $11m
  • Amyris funding round, April 30, 2014: $4m
  • Amyris (company) Convertible note, December 24, 2013: $28m
  • Amyris Convertible note funding round, October 16, 2013: $110m
  • Amyris (company) Debt funding, September 25, 2013: $5m
  • Amyris (company) Convertible note, August 8, 2013: $73.1m
  • Amyris funding round, August 8, 2013: $60m
  • Amyris funding round, December 27, 2012: $42.25m
  • Amyris funding round, July 31, 2012: $38.3m
  • Amyris funding round, May 18, 2012: $4.1m
  • Amyris funding round, February 27, 2012: $83.7m
  • Amyris funding round, November 1, 2011: $12.5m
  • Amyris (company) Initial public offering (IPO), September 28, 2010: $84.8m
  • Amyris Series D round, April 1, 2010: $47.8m
  • Amyris Series C round, October 1, 2009: $41.75m
  • Amyris Series B round: $20m
  • Amyris Series B round, September 19, 2007: $70m
  • Amyris Series A round, October 12, 2006: $20m
  • Amyris funding round, March 2013: $10m
  • Amyris funding round, March 2013: $5m
  • Amyris funding round, December 2009: $24.3m
  • Amyris funding round, June 2010: $133.2m
  • Amyris funding round, March 2010: $47.8m
  • Amyris (company) Grant (money), 2003: $42m
  • Amyris funding round, July 2013: $30m